Cancer Therapy & Research Center (CTRC) Purchases 3 More Theraview Electronic Portal Imaging Devices (EPID) from Acceletronics, Inc.
SAN ANTONIO, TX, LEUSDEN, NL and EXTON, PA, (PRWEB) July 25, 2005
Acceletronics, Inc., a U.S. provider of radiation therapy service and distributor of equipment and parts, today announced that Cancer Therapy & Research Center (CTRC) in San Antonio, Texas, has purchased thee more TheraView LX EPID systems, designed by Dutch manufacturer Cablon Medical BV.
Acceletronics and Cablon have a strategic alliance to market and support the new TheraView Technology line of portal imaging systems. The TheraView ® system, designed for the precise needs of radiation therapy, delivers Clinicians a full scope of imaging and diagnostic features. In addition to DICOM export, high resolution image acquisition and the capability to display dynamic treatment movie loops, the Target Check® automated beam alignment verification software gives the precision and control Clinicians need for both conventional, image guided and intensity modulated radiation therapy (IMRT).
ÂWe were so pleased with the first TheraView we had Acceletronics install for us last year, that we decided to outfit the rest of our treatment machinesÂ, said Mr. Jeff Peyton, Director of Accelerator and Biomedical Engineering, Cancer Therapy & Research Center (CTRC), San Antonio, Texas. ÂThe TheraView EPID has not only freed us from film, darkroom and processor, it has helped us improve quality of care. We have found the TheraView to be a more reliable, less expensive alternative to the OEM offering.Â
ÂWe know by the feedback we are receiving from TheraView end users that the TheraView EPID and itÂs TargetCheck® software is performing very well for both simple and complex portal imaging tasks said James Young, Jr., Vice-President of Acceletronics, Inc. ÂAnd using proven, reliable and less costly leading edge technology for high quality imaging, the TheraView overall cost of ownership represents a savings of over 50% when compared to the amorphous silicon detector systems.Â
About CTRC
Cancer Therapy and Research Center, (CTRC) is located in San Antonio, Texas. The CTRC is a non-profit, free-standing, outpatient international cancer center providing the newest and most up-to-date cancer treatment and research. CTRC celebrated its 30th anniversary in 2004. Since 1974, the CTRC has handled nearly 1 million patient visits, and is expected to handle about 120,000 patient visits in 2005.
About Cablon Medical BV (Theraview Technology).
Based in Leusden, The Netherlands, TheraView Technology division of Cablon Medical develops, manufactures and markets Theraview ® Portal Imaging Systems for use on any medical linear accelerator for radiotherapy. Cablon Medicals business started in 1978, and today includes business units that service and market industry leading solutions for radiology, dialysis, quality assurance and radiotherapy. Cablon Medicals customer base includes leading health care facilities thru-out Europe, as well as the Pacific Rim. Cablon Medical BV is an ISO 9001:2000, ISO 46001:1994 registered company.
For more information, visit http://www.theraview.com.
About Acceletronics, Inc.
Acceletronics specializes in the repair and refurbishing of radiation equipment and provides preventative and emergency maintenance to hundreds of healthcare and industrial radiography facilities. Acceletronics is a distributor of high quality, high technology after market products used to improve quality of cancer patient care. Founded in 1981, Acceletronics, Inc. is one of the worldÂs largest and leading independent radiotherapy equipment service organizations and its subsidiary, RadParts.com, Inc., is among the worldÂs largest suppliers of OEM recommended replacement parts for medical and industrial linear accelerators. Acceletronics is registered to ISO 9001:2000 quality system standards. For more information, visit http://www.acceletronics.com .
All trademarks and registered trademarks are the property of their owners and are used for identification or reference purposes only, with no intent to infringe on copyrights.
###